FN1 and chronic kidney disease: On the other hand, PHGPB could reduce the levels of fibronectin (FN) and transforming growth factor-β 1 (TGF-β1) in mesangial cell lines of diabetic glomerulosclerosis, exhibiting great potential for antifibrosis in chronic kidney disease [151].